- BIOCONNECT: Developing the Action Plan to Foster Baltic Region Innovation Ecosystem in Biotechnology and Synthetic Biology (2023 – 2024)
 |
- SPRINGBOARD: Springboard for excellence in advanced development of antibacterials (2020-2024)
- A4L_ACTIONS: Alliance for Life Sciences – From Strategies to Actions in Central and Eastern Europe (2021-2024)
- InterTAU: Integrative Structural Biology of Pathological tau Protein, an Appealing Therapeutic Target for Alzheimer´s Disease Modifying Drugs (2020-2023)
- Oligomers-MAS-NMR: Structure determination of amyloid oligomers, the pathogenic species in Alzheimer’s disease using fast MAS NMR and microfluidics (2021-2023)
- EU-OPENSCREEN-DRIVE: Driving forward long-term Sustainability of Excellence in Chemical Biology within Europe and beyond (2019-2023)
- FAT4BRAIN: Networking for excellence in functional pharmacology to study the role of fatty acid metabolism in neurological disorders (2019-2023)
- IT-DED³: European Training Network for Integrated Training in Dry Eye Disease Drug Development (2018-2021)
- CARTNET: Combatting Antimicrobial Resistance Training Network (2018-2021)
- Alliance4Life: Life Science Alliance: Closing Research and Innovation Divide in the EU (2018-2019)
- PELICO: Peptidomimetics with Photocontrolled Biological Activity (2016-2019)
- BATCure: Developing New Therapies for Batten Disease (2016-2019)
- BBCE: Baltic Biomaterials Centre of Excellence (2017-2018)
- NIGHTLV-2018-2019: European Researchers’ Night in Latvia 2018-2019 (2018-2019)
- INTEGRATE: Interdisciplinary Training Network for Validation of Gram-Negative Antibacterial Targets (2015-2018)
- NABARSI: New AntiBacterials with Inhibitory Activity on Aminoacyl-tRNA Synthetases (2013 – 2016)
- Innovabalt: Strengthening the research and innovation capacities of the LIOS, the leading Baltic regional centre for drug discovery (2013 – 2017)
 |
ENABLE: European Gram Negative AntiBacterial Engine (2014-2021)
 |
Justice Programme
JUSTSO: Analysis, Knowledge Dissemination, Justice Implementation and Special Testing of Novel Synthetic Opioids (2018-2020)
 |
- Mech@SustInd: Mechanochemistry for Sustainable Industry (2019 – 2023)
- IRENE: Implementation Research Network in Stroke Care Quality (2019 – 2023)
- ERNEST: European Research Network on Signal Transduction (2019-2023)
- European Cholangiocarcinoma Network (2019-2023)
- INNOGLY: Innovation with Glycans: new frontiers from synthesis to new biological targets (2019-2023)
- GLYCONanoPROBES: Functional Glyconanomaterials for the Development of Diagnostics and Targeted Therapeutic Probes (2019-2023)
- New diagnostic and therapeutic tools multidrug resistant tumors (2018-2022)
- Nano2Clinic: Cancer nanomedicine – from the bench to the bedside (2018-2022)
- NutRedOx: Personalized Nutrition in aging society: redox control of major age-related diseases (2017-2021)
- EU-CARDIOPROTECTION: Realising the therapeutic potential of novel cardioprotective therapies (2017-2021)
- BIONECA: Biomaterials and Advanced Physical Techniques for Regenerative Cardiology and Neurology (2017-2021)
- BESTPRAC: The voice of research administrators – building a network of administrative excellence (2014-2019)
- CHAOS: C-H Activation in Organic Synthesis (2016-2020)
- MITOEAGLE: Mitochondrial mapping: Evolution – Age – Gender – Lifestyle – Environment (2016-2020)
- EPICHEM: Epigenetic Chemical Biology (2015-2019)
- Challenging organic syntheses inspired by nature – from natural products chemistry to drug discovery (2015-2019)
- UCNMs: The European upconversion network – from the design of photonupconverting nanomaterials to biomedical applications (2014-2018)
- GLISTEN: GPCR-Ligand Interactions, Structures, and Transmembrane Signalling: a European Research Network (2013 – 2017)
 |
- SYNSTAR: Synergistic Stimulation of Adrenergic Receptors for the Treatment of Obesity (2020-2023)
- SUPERB: Super Biased Ligands for Treatment of Type II Diabetes (2016-2019)
 |
 |
ESIF projects
- PhOAMS: Photocontrol of cell adhesion mechanism (2021-2023)
- BioDrug: Biotechnology at Latvian Institute of Organic Synthesis to Achieve Excellence in Drug Discovery (2019-2023)
| Mutual fund Taiwan–Latvia–Lithuania |
- Development of Lead Inhibitor of carbonic Anhydrase IX as Anticancer Drug (2020 – 2022)
- Development of injectable biomimetic hydrogels for engineering of cartilage tissue (2018-2020)
- Nanoarchitectonics of Metal-Organic Frameworks (MOFs): Design, Dielectric Property, and Organic Catalysis (2017-2019)
- Understanding prion peptide fibril-induced aggregation of prion protein (2017-2019)
- Synthesis and studies of high-triplet-energy materials for blue OLEDs (2017-2019)
- Design of anticancer pharmaceutical compounds using structure and energetics of lead – target interactions (2016-2019)
- New materials and technologies for very-high color rendering and high sunlight spectrum resemblance OLED Lighting Sources (2014 – 2016)
| ERA-NET Projects |
- TENTACLES: Temperature-responsive Nanogels for Targeted Delivery of MicroRNAs in Wound Healing and Tissue Regeneration Applications (2020-2023)
- NANO4GLIO: Nanomedicine for Glioblastoma Therapy (2020-2022)
- RESET-ME: Restoring E. coli Sensitivity for Antibiotics by Blocking TolC-Mediated Efflux (2019-2022)
- EXPLORE: Exploration of the TPP Riboswitch as a New Target for Antibiotics (2019-2022)
- INNOCENT: Innovative Nanopharmaceuticals: Targeting Breast Cancer Stem Cells by a Novel Combination of Epigenetic and Anticancer Drugs with Gene Therapy (2017-2021)
- TRAINS: Time dependent Remote Alteration after Injury to the Nervous (2017-2020)
- THIOREDIN: Development of Thioredoxin Reductase Inhibitors Towards New Anticancer Agents (2018 – 2020)
- TALASA: Targeting Lipoic Acid as Redox and Cofactor Modulator in MRSA (2018-2020)
- PELARGODONT: Engineering and functionalization of delivery system with elargonium sidoides biologically active substance on inflamed periodontal surface area (2017-2019)
- CnsAflame: Neuroinflammatory mechanisms of chronic neurodegeneration and cognitive decline following traumatic brain injury (2016-2019)
- DNA PARYLATION: Study of the new post-replicational modification of DNA by Poly(ADP-ribose) polymerases and its implication for anticancer therapy (2016 – 2018)
- INinRAGI: Screening and developing of a novel family of natural and synthetic HIV Integrase inhibitors which do not interfere with V(D)J recombination (2015 – 2018)
| The joint Ukrainian-Latvian research project |
 |